JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:973-979, doi:10.1016/j.jacc.2006.03.057 (Published online 14 August 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.03.057v1
48/5/973    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T.
Right arrow Articles by Rimm, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T.
Right arrow Articles by Rimm, E. B.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: ATHEROSCLEROSIS

Is Plasma Oxidized Low-Density Lipoprotein, Measured With the Widely Used Antibody 4E6, an Independent Predictor of Coronary Heart Disease Among U.S. Men and Women?

Tianying Wu, MD, PhD*,*, Walter C. Willett, MD, DrPh*,{dagger},{ddagger}, Nader Rifai, PhD||, Iris Shai, PhD*, JoAnn E. Manson, MD, DrPh{dagger},{ddagger},§ and Eric B. Rimm, ScD*,{dagger},{ddagger}

* Department of Nutrition
{dagger} Department of Epidemiology, Harvard School of Public Health
{ddagger} Channing Laboratory
§ Division of Preventive Medicine, Department of Medicine, Harvard Medical School and Brigham & Women's Hospital
|| Department of Laboratory Medicine, Children's Hospital and Harvard Medical School, Boston, Massachusetts

Manuscript received January 6, 2006; revised manuscript received March 17, 2006, accepted March 20, 2006.

* Reprint requests and correspondence: Dr. Tianying Wu, Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115. (Email: tianying{at}hsph.harvard.edu).

OBJECTIVES: Our aim was to examine whether circulating oxidized low-density lipoprotein (oxLDL) is a predictor of coronary heart disease (CHD) independent of lipid markers and to compare oxLDL, apolipoprotein B100 (apoB), and total cholesterol (TC)/high-density lipoprotein-cholesterol (HDL-C) ratio as predictors of CHD.

BACKGROUND: Measurement of circulating oxLDL with antibody 4E6, has been widely used in many studies; however, few large prospective studies have examined whether this marker is a predictor of CHD independent of lipids and compared oxLDL with other important lipid predictors.

METHODS: After 6 years of follow-up among 18,140 men from the HPFS (Health Professionals Follow-up Study) and 8 years among 32,826 women from the Nurses' Health Study who provided blood samples at baseline, we identified incident nonfatal myocardial infarction or fatal CHD in 266 men and 235 women. Each case was matched with two control subjects by age, smoking, and time of blood draw. The oxLDL was measured via enzyme-linked immunosorbent assay with antibody 4E6 against oxidized apoB.

RESULTS: Among both men and women, oxLDL was significantly related to risk of CHD in multivariate analysis before adjustment for any lipid markers. However, when oxLDL, LDL cholesterol, HDL-C, and triglycerides were mutually adjusted, oxLDL was no longer predictive. When oxLDL and apoB were mutually adjusted, only apoB was predictive of CHD. Similar results were found when oxLDL and TC/HDL-C ratio were mutually adjusted.

CONCLUSIONS: Our results suggest that circulating oxLDL, measured with antibody 4E6, is not an independent overall predictor of CHD after adjustment of lipid markers and is less predictive in development of CHD than apoB and TC/HDL-C ratio.

Abbreviations and Acronyms
  ApoB = apolipoprotein B100
  CHD = coronary heart disease
  CI = confidence interval
  ELISA = enzyme-linked immunosorbent assay
  HDL-C = high-density lipoprotein-cholesterol
  LRT = likelihood ratio test
  MI = myocardial infarction
  oxLDL = oxidized low-density lipoprotein
  OR = odds ratio
  RR = relative risk
  TC = total cholesterol


Related Article

Oxidized or Native Low-Density Lipoprotein Cholesterol: Which Is More Important in Atherogenesis?
Jawahar L. Mehta
J. Am. Coll. Cardiol. 2006 48: 980-982. [Full Text] [PDF]



This article has been cited by other articles:


Home page
HeartHome page
C Cote, P Pibarot, J-P Despres, D Mohty, A Cartier, B J Arsenault, C Couture, and P Mathieu
Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis
Heart, September 1, 2008; 94(9): 1175 - 1180.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. R. Rietzschel, M. Langlois, M. L. De Buyzere, P. Segers, D. De Bacquer, S. Bekaert, L. Cooman, P. Van Oostveldt, P. Verdonck, G. G. De Backer, et al.
Oxidized Low-Density Lipoprotein Cholesterol Is Associated With Decreases in Cardiac Function Independent of Vascular Alterations
Hypertension, September 1, 2008; 52(3): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Langlois, E. R. Rietzschel, M. L. De Buyzere, D. De Bacquer, S. Bekaert, V. Blaton, G. G. De Backer, T. C. Gillebert, and on behalf of the Asklepios Investigators
Femoral Plaques Confound the Association of Circulating Oxidized Low-Density Lipoprotein With Carotid Atherosclerosis in a General Population Aged 35 to 55 Years: The Asklepios Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Ky, A. Burke, S. Tsimikas, M. L. Wolfe, M. G. Tadesse, P. O. Szapary, J. L. Witztum, G. A. FitzGerald, and D. J. Rader
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Castilla, A. Davalos, J. L. Teruel, F. Cerrato, M. Fernandez-Lucas, J. L. Merino, C. C. Sanchez-Martin, J. Ortuno, and M. A Lasuncion
Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Wu, N. Rifai, W. C. Willett, and E. B. Rimm
Plasma Fluorescent Oxidation Products: Independent Predictors of Coronary Heart Disease in Men
Am. J. Epidemiol., September 1, 2007; 166(5): 544 - 551.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. K. Schindhelm, M. Alssema, P. G. Scheffer, M. Diamant, J. M. Dekker, R. Barto, G. Nijpels, P. J. Kostense, R. J. Heine, C. G. Schalkwijk, et al.
Fasting and Postprandial Glycoxidative and Lipoxidative Stress Are Increased in Women With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1789 - 1794.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Mehta
Oxidized or Native Low-Density Lipoprotein Cholesterol: Which Is More Important in Atherogenesis?
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 980 - 982.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.